Plasma neurofilament light admission levels and development of axonal pathology in mild traumatic brain injury
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Plasma neurofilament light admission levels and development of axonal pathology in mild traumatic brain injury ; volume:23 ; number:1 ; day:15 ; month:8 ; year:2023 ; pages:1-12 ; date:12.2023
BMC neurology ; 23, Heft 1 (15.8.2023), 1-12, 12.2023
- Creator
-
Hossain, Iftakher
Mohammadian, Mehrbod
Maanpää, Henna-Riikka
Takala, Riikka S. K.
Tenovuo, Olli
Gils, Mark van
Hutchinson, Peter
Menon, David K.
Newcombe, Virginia F.
Tallus, Jussi
Hirvonen, Jussi
Roine, Timo
Kurki, Timo
Blennow, Kaj
Zetterberg, Henrik
Posti, Jussi P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12883-023-03284-6
- URN
-
urn:nbn:de:101:1-2023110310262291468002
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hossain, Iftakher
- Mohammadian, Mehrbod
- Maanpää, Henna-Riikka
- Takala, Riikka S. K.
- Tenovuo, Olli
- Gils, Mark van
- Hutchinson, Peter
- Menon, David K.
- Newcombe, Virginia F.
- Tallus, Jussi
- Hirvonen, Jussi
- Roine, Timo
- Kurki, Timo
- Blennow, Kaj
- Zetterberg, Henrik
- Posti, Jussi P.
- SpringerLink (Online service)
Other Objects (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19: a prospective multicenter study
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19: a prospective multicenter study
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19: a prospective multicenter study
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Repeated lumbar punctures within 3 days may affect CSF biomarker levels